Abbreviations
=============

ACTB/β-actin

:   actin beta

*ATG*

:   autophagy related

Baf

:   bafilomycin

*BECN1*

:   Beclin 1 autophagy related

Doxy

:   doxycycline

EBV

:   Epstein-Barr virus

EM

:   electron microscopy

KSHV

:   Kaposi\'s sarcoma-associated herpesvirus

MAP1LC3/LC3

:   microtubule-associated protein 1 light chain 3

PBS

:   phosphate-buffered saline

PEL

:   primary effusion lymphoma

RAB7

:   RAB7 member RAS oncogene family

SD

:   standard deviation

T/B

:   TPA/sodium butyrate

TPA

:   2-O-tetradecanoylphorbol-13-acetate

TUBA1A/α-tubulin

:   tubulin alpha 1a

VZV

:   varicella zoster virus.

Introduction {#s0001}
============

Kaposi\'s sarcoma-associated herpesvirus (KSHV) belongs to the human gamma-herpesvirus subfamily, *Rhadinoviridae* genus.[@cit0001] It is associated with Kaposi\'s sarcoma and some hematological malignancies, such as primary effusion lymphoma and multicentric Castleman disease.[@cit0002] KSHV infection of tumor cells is mostly latent, but it can be switched into lytic cycle either in vivo or in vitro upon appropriate stimuli such as exposure to 12-O-tetradecanoylphorbol-13-acetate (TPA) alone or in combination with sodium butyrate (T/B),[@cit0003] Bortezomib,[@cit0006] ORF50 expression[@cit0007] and doxycycline in TRExBCBL1-Rta cells.[@cit0008] Upon the activation of the lytic cycle, different sets of KSHV genes can be expressed:[@cit0009] immediate early (e.g., K-bZIP),[@cit0010] early (e.g., ORF69)[@cit0012] and late (e.g., K8.1).[@cit0013] Autophagy is a process of self-degradation of cellular components, upregulated in tumor cells and in stressful conditions. This is a multistep process regulated by the autophagy-related (*ATG*) genes.[@cit0014] The vesicle nucleation, that represents the first step of autophagy, is dependent on the class III phosphatidylinositol 3-kinase complex formed by PIK3C3/Vps34 (mammalian/yeast protein), PIK3R4/Vps15, BECN1/Vps30/Atg6, and ATG14/Atg14. Among them BECN1/Beclin 1, has a central role in this process, since it interacts with molecules that regulate autophagy at several steps.[@cit0015] A marker of the autophagic vacuoles is MAP1LC3/LC3 (microtubule-associated protein 1 light chain 3), an ortholog of yeast Atg8, that is expressed as a full-length cytosolic protein and upon autophagy induction is cleaved by ATG4 to form LC3-I, which is then conjugated to phosphatidylethanolamine generating LC3-II. In the last autophagic phases, autophagosomes, transporting intracellular proteins, fuse with lysosomes. Autophagosomes can also transport intracellular microorganisms to the lysosomes, contributing to the clearance of the microbial infections.[@cit0016] For that reason viruses, especially those that persist in the infected host, subvert autophagy to avoid their own elimination.[@cit0017] However, exceptions have been described and, for example, among herpesviruses, varicella zoster virus (VZV) is able to establish a successful infection without affecting the autophagic process in the host cells.[@cit0018] In contrast, KSHV encodes several proteins that block autophagy at multiple levels[@cit0019] even if autophagy has been shown to be activated and to promote the KSHV lytic cycle.[@cit0022] In this study, besides confirming that autophagy is activated concomitantly with the KSHV lytic cycle in 2 different PEL cell systems and that autophagy promoted viral lytic gene expression, we found that the late autophagic steps were blocked, as indicated by several lines of experimental evidence. Thus, the autophagic block might represent a mechanism that allows KSHV to avoid reaching the lysosomes and be degraded by the lysosomal proteases. Meanwhile, this strategy enables KSHV to hijack the autophagic machinery to travel toward the cell surface. Based on the results obtained in this study, we suggest that autophagy manipulation could be exploited to reduce viral replication and consequently to improve the outcome of therapies against KSHV-associated malignancies, whose pathogenesis correlates with continuous viral release.

Results and Discussion {#s0002}
======================

BC3 and BCBL1 PEL cells were treated with TPA (20 ng/ml) and sodium butyrate (0.3 mM) combined (T/B) for 36 h, to induce the KSHV lytic cycle. We found that at this time, when the KSHV lytic cycle was activated (as indicated by K-bZIP lytic antigen expression), the level of the lipidated form of LC3 (LC3-II) increased in comparison to the onset of viral replication (time 0) and to untreated controls (-) in both PEL cell lines ([**Fig. 1A**](#f0001){ref-type="fig"}). Of note, in BCBL1 cells a certain amount of spontaneous viral replication occurred (indicated by the low expression of K-bZIP in the untreated cells) and concomitantly a higher basal level of LC3-II was also detected. Then, BC3 and BCBL1 cells were transfected with a pEGFP-LC3 plasmid and treated with T/B.[@cit0024] We found that autophagosomes, revealed by GFP-LC3 puncta, accumulated in PEL cells undergoing KSHV replication and expressing K8.1 membrane antigen ([**Fig. 1B**](#f0001){ref-type="fig"}). The majority of replicating cells (about 70%) showed GFP-LC3 puncta; conversely, only 10% of the cells not undergoing KSHV replication, showed GFP-LC3 puncta (data not shown), suggesting that autophagy was induced during KSHV lytic cycle activation. We then stably transfected BC3 cells with a pEGFP-LC3 plasmid, to avoid artifactual results[@cit0014] and quantified the number of LC3-positive BC3 cells, induced or not to enter the KSHV lytic cycle by T/B for 0, 18, 36 and 60 h. The results shown in [**Fig. 1C**](#f0001){ref-type="fig"} indicate that the number of GFP-LC3-positive cells (containing at least 5 GFP-LC3 puncta)[@cit0026] increased up to 36 h of T/B treatment, whereas it was slightly changed in the untreated control cells. Similar results were obtained with transiently pEGFP-LC3 plasmid-transfected BC3 cells ([**Fig. 1D**](#f0001){ref-type="fig"}). For these quantitative experiments we counted about 200 cells induced or not to enter the lytic cycle, for each time point. The accumulation of LC3-II as well as of autophagosomes suggest the activation of the autophagic process, but they do not make it possible to assess the completeness of the autophagic flux, since both LC3-II and autophagosomes are formed and degraded during autophagy induction.[@cit0014] Figure 1.T/B activates autophagy concomitant with KSHV lytic cycle induction in PEL cells. (**A**) Western blot analysis showing the accumulation of the lipidated form of LC3 (LC3-II) concomitant with the expression of K-bZIP lytic cycle antigen induced by TPA at 20 ng/ml and sodium butyrate at 0.3 mM (T/B) upon 36 h of treatment in BC3 and BCBL1 cells, in comparison to the untreated control. LC3-I/-II as well as K-bZIP at the onset of the viral lytic cycle are also shown. TUBA1A/α-tubulin was used as loading control and a representative experiment out of 3 is shown. The histograms represent the mean plus standard deviation (SD) of the densitometric analysis of the ratio of K-bZIP or LC3-II to TUBA1A of 3 different experiments. (**B**) PEL cells were transfected with pEGFP-LC3 plasmid before inducing the lytic cycle with T/B. Autophagy activation was revealed by the appearance of GFP-LC3 puncta (green) and the cells undergoing KSHV lytic cycle were indicated by the expression of KSHV K8.1, a membrane lytic protein, by using a specific monoclonal antibody (red staining). Bar: 5 micron. (**C**) BC3 cells were stably transfected with pEGFP-LC3 plasmid and quantification of cells expressing more than 5 GFP-LC3 puncta per cell (as evaluated by immune fluorescence microscopy) was performed in both unreactivated and T/B reactivated PEL cells at 4 time points: 0, 18, 36 and 60 h. (**D**) BC3 cells were transiently transfected with pEGFP-LC3 plasmid and quantification of cells expressing more than 5 GFP-LC3 puncta per cell (as evaluated by immune fluorescence microscopy) was performed in both unreactivated and T/B reactivated PEL cells at 4 time points: 0, 18, 36 and 60 h. About 200 cells were counted for each time point.

To shed more light on this process, we added bafilomycin A~1~ (Baf; 20 nM) to PEL cells, during the last 3 h of T/B treatment. Baf, as an inhibitor of the vacuolar-type H^+^-ATPase, prevents LC3-II degradation and allows the evaluation of total LC3-II formation. We found that the LC3-II level did not increase after 36 h of T/B treatment in combination with Baf ([**Fig. 2A**](#f0002){ref-type="fig"}), a time at which the KSHV lytic cycle was induced (evidenced by the expression of the KSHV lytic antigen K-bZIP), suggesting the occurrence of an autophagic block during KSHV replication. In contrast, a complete autophagic flux was observed in BJAB, a KSHV-negative lymphoma cell line, undergoing 36 h of T/B treatment ([**Fig. 2B**](#f0002){ref-type="fig"}). Concomitant with the lytic cycle activation and the autophagic block, we found that expression of RAB7 (a member of the RAS oncogene family) was reduced in BC3 cells ([**Fig. 2A**](#f0002){ref-type="fig"}). RAB7,[@cit0027] besides regulating lysosome biogenesis,[@cit0028] plays an important role in the fusion of autophagosomes with lysosomes, a step required for a complete autophagic flux.[@cit0029] Next, a kinetic evaluation of the expression of K-bZIP, RAB7 and LC3-I/-II was performed after 0, 9, 18 and 36 h of T/B treatment in the presence or in the absence of Baf. As shown in [**Figure 2C**](#f0002){ref-type="fig"}, when the KSHV lytic cycle was induced, RAB7 expression was reduced and an autophagic block occurred, based on the change in the level of LC3-II in the presence or in the absence of Baf. Figure 2.The autophagic flux was blocked in BC3 cells undergoing KSHV lytic cycle activation. (**A**) Analysis of K-bZIP lytic antigen, RAB7 and LC3-I/-II expression in the presence or in the absence of Baf (used for the last 3 h at 20 nM) in BC3 cells induced to enter the lytic cycle by T/B treatment for 36 h or (**B**) in the KSHV-negative BJAB cells undergoing the same treatment. (**C**) Kinetic analysis of the expression of K-bZIP, RAB7 and LC3-II and effects of Baf on the expression of K-bZIP, RAB7 and LC3-II in BC3 cells induced to enter the lytic cycle by T/B at the indicated time points. ACTB was used as loading control and a representative experiment out of 3 is shown. The histograms represent the mean plus SD of the densitometric analysis of the ratio of specific proteins to ACTB of 3 different experiments. (**D**) BC3 cells were transfected with pEGFP-LC3 plasmid and induced to enter the lytic cycle by T/B treatment for 0, 18 and 36 h. Lysosomes were stained in red with LysoTracker while autophagosomes were indicated by GFP-LC3 puncta. Bar: 5 micron. (**E**) Gallery of BC3 cells transfected with pDest-mCherry-EGFP-LC3B plasmid and treated with T/B for 36 h or starved for 2 h. The yellow puncta indicate autophagosomes while red puncta indicate autolysosomes. A representative experiment out of 3 is shown. Bar: 5 micron.

Then, to further analyze the autophagic flux, we investigated the localization of autophagosomes and lysosomes and observed that in the majority of PEL cells treated with T/B for 36 h, the GFP-LC3 puncta (stained in green and indicating autophagosomes) did not colocalize with the lysosomes (stained in red with LysoTracker Red). Conversely, at earlier time points some of the autophgosomes and lysosomes colocalized, as indicated by the appearance of yellow puncta ([**Fig. 2D**](#f0002){ref-type="fig"}). These results are in agreement with those obtained for LC3-II in the presence of Baf by western blot analysis ([**Fig. 2C**](#f0002){ref-type="fig"}) and suggest that the autophagic flux was complete during the first 18 h of T/B treatment, whereas it was blocked when the KSHV lytic antigens start to be expressed. Finally, by transfecting BC3 cells with the pDest-mCherry-EGFP-LC3B plasmid,[@cit0030] we found that in T/B-treated cells most of the autophagic structures displayed yellow fluorescence, due to the concomitant expression of mCherry and GFP, corresponding to autophagosomes. In contrast, the GFP component of the fluorescence was decreased by the complete autophagic flux induced by starvation in the same cells (due to instability of GFP in the lysosome) and consequently most of the autophagic structures appeared red, corresponding to autolysosomes ([**Fig. 2E**](#f0002){ref-type="fig"}). These results further suggest that the KSHV lytic cycle activation might impair the fusion between autophagosomes and lysosomes in PEL cells.

We then investigated the completeness of the autophagic flux in a different cell system, the TRExBCBL1-Rta cells. We observed that an autophagic block occurred also in these cells induced to enter the lytic cycle by doxycycline treatment for 48 h while a complete autophagy was observed in TRExBCBL1-vector control cells undergoing doxycycline treatment for the same time ([**Fig. 3A**](#f0003){ref-type="fig"}). The efficiency of lytic cycle induction by doxycycline in TRExBCBL1-Rta cells was analyzed in the same cells either by western blot ([**Fig. 3B**](#f0003){ref-type="fig"}) or by immunofluorescence ([**Fig. 3C**](#f0003){ref-type="fig"}), to further confirm that a block of the autophagic flux was occurring concomitantly with KSHV lytic cycle activation. Upon lytic cycle activation, we found that RAB7 was downregulated also in these cells ([**Fig. 3B**](#f0003){ref-type="fig"}), suggesting that it could be one of the mechanisms underlying the block of autophagy at the final steps during KSHV replication. Then, to demonstrate that the reduction of RAB7 would lead to a block of autophagy in PEL cells, we silenced this molecule by specific siRNA ([**Fig. 4A**](#f0004){ref-type="fig"}) and found that indeed LC3-II did not further increase in the presence of Baf in RAB7 knockdown cells ([**Fig. 4B**](#f0004){ref-type="fig"}). A reduction of RAB7 expression was also previously observed during the replication of Epstein-Barr virus (EBV),[@cit0017] another member of the gamma-herpesviruses subfamily, *Lymphocryptoviridae* genus, suggesting that it represents a common feature during gamma-herpesvirus replication. Moreover, the results obtained in this study are in agreement with a recent paper reporting that the transfection of the KSHV K7 lytic protein impaired the fusion of autophagosomes with lysosomes in HeLa cells, in which autophagy was induced by rapamycin. [@cit0031] Figure 3.The autophagic flux was blocked in TRExBCBL1-Rta cells undergoing KSHV lytic cycle activation by doxycycline treatment. (**A**) Evaluation of the autophagic flux based on LC3-II accumulation in the presence or in the absence of Baf (used for the last 3 h at 20 nM) in TRExBCBL1-Rta cells induced to enter the lytic cycle by treatment with doxycycline for 48 h. TRExBCBL1-vector cells were used as control. (**B**) The expression of KSHV lytic antigen K8.1 and RAB7 was analyzed by western blot. TUBA1A was used as loading control and a representative experiment out of 3 is shown. The histograms represent the mean plus SD of the densitometric analysis of the ratio of LC3-II, K8.1 or RAB7 to TUBA1A of 3 different experiments. (**C**) Percentage of cells expressing K8.1 (red) lytic antigen analyzed by immunofluorescence. Nuclei were stained by DAPI (blue). Figure 4.RAB7 knockdown leads to an autophagic block in PEL cells. BCBL1 cells were knocked down for RAB7 or scramble (SC) treated and (**A**) RAB7 and (**B**) LC3-II expression level was evaluated in the presence or in the absence of Baf. TUBA1A was used as loading control and a representative experiment out of 3 is shown. The histograms represent the mean plus SD of the densitometric analysis of the ratio of LC3-II to TUBA1A of 3 different experiments.

Next, to investigate the role of autophagy in the KSHV lytic cycle, we knocked down *BECN1*, a gene essential for the autophagic process, before inducing the lytic cycle with T/B. We found that KSHV K-bZIP lytic protein expression was reduced in *BECN1*-silenced BC3 cells in comparison to the scramble control ([**Fig. 5A**](#f0005){ref-type="fig"}). Accordingly, the number of cells expressing K-bZIP was strongly reduced by *BECN1* knockdown ([**Fig. 5B**](#f0005){ref-type="fig"}). Similar results were obtained by *ATG5* silencing (data not shown). These results indicate that autophagy promoted the KSHV lytic cycle, in agreement with a recent study[@cit0022] and similarly to what we and other authors have previously observed during EBV replication.[@cit0017] Finally, by electron microscopy (EM) analysis, autophagic features were observed in the majority of virus-producing cells and about 30% of viral particles were contained within the double-membrane autophagic vesicles present in the cytoplasm of PEL cells induced to enter the KSHV lytic cycle (200 cells were analyzed; [**Fig. 5C**](#f0005){ref-type="fig"}). Based on this observation and on the negative effect of autophagy inhibition on viral lytic expression, we propose that KSHV, similarly to EBV, might exploit the autophagic machinery for its transport, to enhance viral production. The study of the mechanisms that regulate KSHV lytic cycle activation are of fundamental importance since KSHV-associated malignancies, such as Kaposi\'s sarcoma, are characterized by a continuous release of viral particles that contributes to the disease\'s maintenance.[@cit0035] The finding that autophagy is involved in KSHV replication suggests that manipulation of this process could lead to a better control of viral production and could restrain the progression of KSHV-associated malignancy diseases. Figure 5.Autophagy enhances the KSHV lytic cycle. (**A**) K-bZIP expression was evaluated by western blot analysis in BC3 cells transfected with scramble (SC) or *BECN1* siRNA for 48 h and then induced to enter the lytic cycle by 36 h of T/B treatment. GAPDH was used as a loading control and a representative experiment out of 3 is shown. The histograms represent the mean plus SD of the densitometric analysis of the ratio of BECN1 or K-bZIP to GAPDH of 3 different experiments. (**B**) BC3 cells transfected with scramble (SC) or *BECN1* siRNA for 48 h and then induced to enter the lytic cycle by 36 h of T/B were analyzed for K-bZIP (red) expression by immunofluorescence. Nuclei were stained by DAPI (blue). The histograms represent the mean plus SD of the percentage of K-bZIP-positive cells of 3 different experiments. (**C**) Electron microscopy analysis of BC3 cells induced to enter the lytic cycle by T/B. Autophagic vacuoles containing viral particles (arrows) were observed in the cytoplasm of BC3 virus-producing cells. Au, autophagosomes; er, endoplasmic reticulum; G, Golgi apparatus; M, mitochondrion; N, nucleus. Bar: 0.5 μm.

Materials and Methods {#s0003}
=====================

Cell culture and reagents {#s0003-0001}
-------------------------

BC3 (ATCC, CRL-2277), BCBL1 (kindly provided by Prof. P. Monini, National AIDS Center, Istituto Superiore di Sanità, Rome, Italy), TRExBCBL1-Rta (kindly provided by Prof. J. Jung, Dept. of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, Los Angeles, California, USA) and TRExBCBL1-vector (kindly provided by Prof. J. Jung, Dept. of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, Los Angeles, California, USA)[@cit0008] are human B-cell lines derived from PEL-carrying latent KSHV. BJAB is an EBV-negative Burkitt lymphoma cell line (kindly provided by Prof. MG Masucci, Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm), Sweden). The cells were cultured in RPMI 1640 (Sigma, R0883), 10% fetal calf serum (Euroclone, ECLS0180L), [L]{.smallcaps}-glutamine and streptomycin (100 µg/ml) and penicillin (100 U/ml) (Gibco, 10378-016) in 5% CO~2~ at 37°C. TRExBCBL1-Rta and TRExBCBL1-vector cell lines (kindly provided by Prof. J. Jung) were cultured using the same medium in the presence of hygromycin (100 µg/ml) (Sigma Aldrich, H0654) and blasticidin (100 µg/ml; Santa Cruz Biotechnology, sc-204655A) in 5% CO~2~ at 37°C. The KSHV lytic cycle was induced in BC3 and BCBL1 cells by treatment with TPA (20 ng/ml; Sigma Aldrich, P8139) and sodium butyrate (0.3 mM; Sigma Aldrich, B5887) for the indicated times. Otherwise, the viral replication in TRExBCBL1-Rta cells was activated by treatment with doxycycline (1 µg/ml) (Sigma, D1822) for the indicated times. To investigate autophagy, the cells were treated with Baf (20 nM; Santa Cruz Biotechnology, sc-201550) for the last 3 h.^25^

A stable BC3 cell line expressing GFP-LC3 was grown in complete RPMI medium supplemented with 0.8 mg/ml geneticin/G418 (Life Technologies, 10131-027)

Antibodies {#s0003-0002}
----------

In western blotting analysis, we used in this work the following primary antibodies: mouse monoclonal anti-K-bZIP (1:500; Santa Cruz Biotechnology, sc-69797), mouse monoclonal anti-K8.1 (1:400; ABI Advanced Biotechnologies, 13-213-100) and rabbit polyclonal anti-RAB7 (1:500; Santa Cruz Biotechnology, sc-10767). To study autophagy we used the following primary antibodies: rabbit polyclonal anti-LC3 (1:1000; Novus Biologicals, NB100-2220SS) and rabbit polyclonal anti-BECN1 (1:1000; Cell Signaling Technology, 3738S).

Monoclonal mouse anti-TUBA1A/α-tubulin (1:1000; Sigma Aldrich, T6199), anti-ACTB/β−actin (1:10000; Sigma Aldrich, A5441) and anti-GAPDH (Santa Cruz Biotechnology, sc-13717) were used as loading controls. The goat polyclonal anti-mouse IgG-HRP (Santa Cruz Biotechnology, sc-2005) and anti-rabbit IgG-HRP (Santa Cruz Biotechnology, sc-2004) were used as secondary antibodies. All the primary and secondary antibodies were diluted in phosphate-buffered saline (PBS; Sigma Aldrich, D8537) -0.1% Tween 20 (Sigma Aldrich, P1379) solution containing 3% BSA (Serva, 11943.03)

Western blot analyses {#s0003-0003}
---------------------

1 × 10^6^ cells were washed twice with 1X PBS-0.1% Tween 20 solution and centrifuged at 212 x g for 5 min. The pellet fraction was lysed in a RIPA buffer containing 150 mM NaCl, 1% NP-40 (Sigma Aldrich, NP40S), 50 mM Tris-HCl, pH 8, 0.5% deoxycholic acid (Sigma Aldrich, D6750), 0.1% SDS (Sigma Aldrich,71736), protease (Sigma Aldrich, S8830) and phosphatase inhibitors (Sodium Orthovanadate; Sigma Aldrich, S6508) (Sodium Fluoride; Sigma Aldrich, S7920). Then, 30 µg of protein lysates were subjected to electrophoresis on 4-12% NuPage Bis-Tris gels (Life Technologies, N00322BOX) according to the manufacturer\'s instruction. To evaluate the LC3-I/-II, the cell lysates were denatured in 3X Loading Protein Buffer (150 mM Tris-HCl, pH 6.8, 6% SDS, 30% glycerol, 30 mM EDTA, 0.2% Bromophenol Blue) for 5 min at 100°C and run on a 15% gel (30% acrylamide/Bis Solution 29:1; Bio-Rad, 161-0159) in Tris-glycine-SDS buffer (Bio-Rad, 1610772). Then, the gels were transferred to nitrocellulose membranes (Bio-Rad, 162-0115) for 2 h in Tris-glycine buffer. The membranes were blocked in PBS-0.1% Tween 20 solution containing 3% BSA, probed with specific antibodies and developed using ECL Blotting Substrate (Advansta, K-12045-D20).

Electron microscopy analysis {#s0003-0004}
----------------------------

PEL cells were treated with TPA (20 ng/ml) and sodium butyrate (0.3 mM) at the indicated times. Subsequently, cells were fixed in 2% glutaraldehyde (Electron Microscopy Sciences, 111-30-8) in 1X PBS for 24 h at 4°C, post-fixed in 1% OsO~4~ (Agar Scientific, R1016) for 2 h and stained for 1 h in 1% aqueous uranyl-acetate (Electron Microscopy Sciences, 22400). The samples were then dehydrated with graded acetone and embedded in Epon-812 (Electron Microscopy Sciences, 14120). One-micron thick sections were cut, stained with 1% methylene blue and viewed by light microscopy to select representative areas. Ultrathin sections were cut with a Reichert ultramicrotome, counterstained with uranyl acetate and lead citrate, and examined with a Philips CM10 transmission electron microscope (FEI).

Knockdown by small interfering RNA {#s0003-0005}
----------------------------------

The knockdown of BECN1 (Santa Cruz Biotechnology, sc-29797) or RAB7 (Santa Cruz Biotechnology, sc-29460) was performed in PEL cell lines using specific small interfering RNA duplex. The day before transfection, 3 × 10^5^ cells were seeded in 12-well culture plates in RPMI medium without antibiotics. Subsequently, 75 pmol of siRNA duplex and 7.5 µl of Lipofectamine 2000 Transfection Reagent (Life Technologies, 11668027) were diluted in Optimem medium (Life Technologies, 31985062) and added to the cells for 48 h. The transfection efficiency was evaluated by a Fluorescein Conjugate-A siRNA (Santa Cruz Biotechnology, sc-36869), which was also used as a scrambled control.

Transfection and plasmids {#s0003-0006}
-------------------------

We performed a transient transfection using the pEGFP-LC3 plasmid (kindly provided by Prof. G.M. Fimia, National Institute for Infectious Disease 'L. Spallanzani' IRCCS, Rome, Italy)[@cit0024] or pDest-mCherry-EGFP-LC3B plasmid (kindly provided by Prof. T. Johansen, Molecular Cancer Research Group, Institute of Medical Biology, University of Tromsø and The Arctic University of Norway, Tromsø, Norway)[@cit0030] in PEL cell lines. 5 × 10^5^ cells were seeded into 6-well plates and then transfected with 5 µg of plasmid DNA/well with Lipofectamine 2000 according to the manufacturer\'s instructions. After 48 h, the cells were treated with TPA (20 ng/ml) and sodium butyrate (3 mM) for the indicated times. In order to activate autophagy, BC3 cells were transfected with pDest-mCherry-EGFP-LC3B for 48 h and then were cultured in Hank\'s balanced salt solution (Sigma Aldrich, E6267) medium for 3 h. The pDest-mCherry-EGFP-LC3B plasmid makes it possible to visualize the autophagic steps because the LC3 puncta, indicating autophagosomes arising during autophagy induction, change their color depending on the pH; they appear yellow when both green and red colors are expressed, but when autophagosomes fuse with lysosomes the GFP is unstable and autolysosomes become red. The LC3 dots were visualized with an Apotome Axio Observer Z1 inverted microscope (Zeiss, Germany) equipped with an AxioCam MRM (Zeiss, Germany) Rev.3 at 40 × magnification.

We generated a stably transfected BC3 cells with a plasmid expressing GFP-LC3. Briefly, 5 × 10^5^ BC3 cells were cultured into 6-well plates and transfected with 5 µg of pEGFP-LC3 plasmid/well with Lipofectamine 2000 according to the manufacturer\'s instructions. After 48 h, the cells were resuspended in a medium containing 1.5 mg/ml of G418 and seeded in 96-well plates. After 10-14 d, the GFP-LC3-positive clones were isolated and selected by fluorescence microscopy.

Immunofluorescence {#s0003-0007}
------------------

KSHV replication was activated with the lytic cycle inducers in PEL cell lines, as previously described. The cells were harvested, washed twice in 1X PBS and then incubated with mouse monoclonal anti-K8.1 antibody (1:300 in PBS; ABI Advanced Biotechnologies, 13-213-100) for 1 h on ice. Subsequently, they were washed 3 times in cold 1X PBS and incubated with polyclonal Cy3-conjugated sheep-anti mouse (1:100 in 1X PBS; Jackson Immunoresearch Laboratories, 515-165-062) for 30 min on ice. Finally, after several washing, the cells were resuspended in a 1X PBS-glycerol solution (1:1).

After BECN1 silencing, KSHV replication was induced by TPA (20 ng/ml) and sodium butyrate (0.3 mM) at the indicated times in BC3 cells. Cells were then harvested, washed twice in PBS, seeded on glass slides, air dried and permeabilized/fixed in acetone-methanol (1:1) for 10 min. The slides were then incubated with mouse monoclonal anti-K-bZIP antibody for 1 h. They were washed 3 times in 1X PBS and incubated with polyclonal Cy3-conjugated sheep-anti mouse for 30 min. Finally, after several washings, cells were incubated with 4,6-diamidino-2-phenylindole (DAPI) to visualize the nuclei and the coverslips were mounted face down using a PBS-glycerol (1:1) solution. The immunofluorescence was analyzed using an Apotome Axio Observer Z1 inverted microscope, equipped with an AxioCam MRM Rev.3 at 40 × magnification.

LysoTracker Red staining {#s0003-0008}
------------------------

BC3 cells transfected with pEGFP-LC3 were treated with TPA (20 ng/ml) and sodium butyrate (0.3 mM) for the indicated times, washed in PBS solution, and incubated with LysoTracker Red DND-99 (100 nM; Life Technologies, L7528), a fluorescent acidotropic probe with high selectivity for acidic organelles, for 30 min at room temperature.[@cit0035] After several washings with PBS solution, the lysosomes were analyzed using an Apotome Axio Observer Z1 inverted microscope equipped with an AxioCam MRM Rev.3 at x40 magnification.

Densitometric analysis {#s0003-0009}
----------------------

The quantification of proteins bands was performed by densitometric analysis using the ImageJ software, which was downloaded from the NIH web site (<http://imagej.nih.gov>).

Statistical analysis {#s0003-0010}
--------------------

All data are represented by the mean ± standard error of at least 3 independent experiments.
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